CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 4th Interim Announcement
CompuGroup Medical SE & Co. KGaA
/ Share Buy-Back
Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 4th Interim Announcement In the period from December 20, 2021 until and including December 23, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 81,829 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on November 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on November 26, 2021. The aggregate number of shares bought back each day during the period from December 20, 2021 until and including December 23, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows:
The aggregate number of shares bought back within the share buy-back program in the period from November 26, 2021 until and including December 23, 2021 amounts to 326,685 shares. Detailed information about the transactions are published on the company’s website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, December 28, 2021 CompuGroup Medical SE & Co. KGaA
28.12.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Internet: | www.cgm.com |
End of News | DGAP News Service |